Prof. Kevin Ault, Gynaecologist, from the Emory
University School of Medicine, University of
Iowa, USA has present the results of the last
Study's conclusions are Incredible and it's true;
he told about a vaccine, that is 100 % effective
in preventing the most common types of Cervical
cancer linked to HPV (D3-to see).

The HPV infections are sexually transmitted
diseases which prepare the way for cervical
cancer. We can protect the women against the most
Carcinogenic subtypes (6, 11, 16 and 18 of HPV)
which are the cause of More than 70 % of cervical
cancers.

With optimistic results of the Future II study,
20541 Women from Europe, America and Asia,
between the ages of 16 and 26 years old, was
involved in this extensive project. Of course,
the methodological rules, as a blind Study
compared the quadrivalent vaccine do a placebo.
The Vaccine protected the young women completely
against precancerous Lesions (medium - or
high-grad) of the Cervix related to HPV 16 and
18. The protection result was 100 % of cases! The
sid-effects comes with an extremely low number.
If we see the large number of cases in this
study, the results should be the same if
vaccination is made Available to the public.

We should not forget - the Cervical Cancer is the
second leading cancer in Young women and accounts
for 11 % of Cancers in all women! When the Women
has a common genital Infection with the human
papillomavirus (HPV) and its can result in the
appearance of precancerous lesions of the Cervix
Mucous membrane. For instance, we know that the
connection between HPV infection and cervical
cancer is much stronger than that between smoking
and lung cancer.

How the researcher has got these results? With
this new quadrivalent vaccine for cervical
cancer, the most oncogenic subtypes of HPV can
now be whipped out. One of the first steps is
vaccinating adolescents (D3-"Chronical") Before
they come into contact with the virus; - Results
- No virus, no Lesions - no cancer! Prevention -
the essential part of the combating Cervical
Cancer.

The most oncogenic subtypes of HPV can now be
wiped out thanks to this new quadrivalent
vaccine. The first step is vaccinating
adolescents (D3 - "Chronical") before they come
into contact with the virus; this is a turning
point in the fight against cancer. It is a major
tool in the prevention of precancerous lesions in
the cervix. No virus, no lesions - and if there
are no lesions, that means no cancer. Prevention
is an essential part of the equation when it
comes to combating cervical cancer - that's why
oncologists are so excited about the new Vaccine.

A study conducted with more than 20,000 women has
shown the absolute effectiveness of a vaccine in
the prevention of cervical cancer due to the most
common types of human papillomavirus (HPV).
Oncologists are enthusiastic. It is a rare thing
to hear physicians - and even more so,
oncologists -get excited to the point of speaking
of a "historical breakthrough" after hearing a
presentation from a colleague.

Prof. Thomas Turz, Director of the Institute
Gustave Roussy at the ECCO conference has say -
It is a rare thing to hear physicians - and even
more so, oncologists -get excited to the point of
speaking of a "historical breakthrough" after
hearing a presentation from a colleague. The
Oncologists are enthusiastic.

Health-Service-Online
http://www.cancer-info.info


About The Author:

Fritz Frei make it easy to check out the important details about the diagnoses and test's of the Cervical Cancer. To receive more information's about all cancer -questions - Links and last research NEW's - visit the http://www.cancer-info.info